INHALATION OF NITRIC OXIDE

A method of treating a human subject which is effected by inhalation of gaseous nitric oxide, the method comprising a first treatment period comprising administering gNO by inhalation over a period of about at least 5 days, wherein the first treatment period is followed by a second treatment period comprising administering gNO by inhalation over a period of at least 3 months. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

AVNIEL AMIR [VerfasserIn]
ARDAKANI ALI [VerfasserIn]
LISI STEVEN A [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61M: Devices for introducing media into, or onto, the bo (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che
G01N: Investigating or analysing materials by determining (...)
med

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-06-21, Last update posted on www.tib.eu: 2023-07-06, Last updated: 2023-07-14

Patentnummer:

EP3703660

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA004433319